Pfizer, Merck, Bausch Health, Viatris, and Santen Pharmaceutical are listed as key companies in glaucoma trials.
1 report, 1 independent
Updated Jul 31
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer, Merck, Bausch Health, Viatris, and Santen Pharmaceutical are listed as key companies in glaucoma trials.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Merck
public company in Indonesia
-
Bausch Health
multinational specialty drugs company based in Laval, Quebec, Canada
Nothing else this week.
Related events
- MarketBeat is providing analyst ratings and tracking the competitive landscape between healthcare companies Pfizer and Lyra Therapeutics.
- Roivant Sciences licensed a drug from Pfizer for regulatory approval.
- Pfizer, Merck, and Amgen are large-cap drugmakers with significant operations in the United States.
Coverage
Newest first; wire copies grouped- GlobeNewswireGlaucoma Global Clinical Trials Market Landscape Report 2025 Featuring Alcon, AbbVie, Santen Pharmaceutical, Pfizer, Kowa, Viatris, Merck, Novartis, Senju Pharmaceutical, Bausch Health Discover insig